Stock slips after beating expectations but cutting guidance

  • CVS Health Corp. beats fourth-quarter earnings expectations
  • Net income falls to $2.05 billion, adjusted EPS beats consensus
  • Revenue grows 11.9% to $93.81 billion
  • Full-year outlook lowered due to elevated medical costs
  • Stock slips 0.3% in premarket trading

Shares of CVS Health Corp. fell 0.3% in premarket trading after the company reported fourth-quarter results that beat expectations. Net income for the quarter fell to $2.05 billion, but adjusted earnings per share of $2.12 surpassed the consensus estimate. Revenue grew 11.9% to $93.81 billion, driven by increases in health care benefits, health services, and pharmacy and consumer wellness revenue. However, CVS lowered its full-year outlook due to elevated medical costs, reducing its adjusted EPS guidance for 2024. The stock has gained 5% over the past three months.

Public Companies: CVS Health Corp. (CVS)
Private Companies:
Key People:


Factuality Level: 8
Justification: The article provides factual information about CVS Health Corp.’s fourth-quarter results, including net income, adjusted earnings per share, and revenue. It also mentions the company’s lowered full-year outlook. The information is supported by data from FactSet. There are no digressions, misleading information, sensationalism, redundancy, or opinion masquerading as fact. The article is concise and focused on the main topic.

Noise Level: 7
Justification: The article provides relevant information about CVS Health Corp’s fourth-quarter results and its impact on the stock market. However, it lacks in-depth analysis of the reasons behind the lowered full-year outlook and the potential consequences for the company and its stakeholders. The article also does not provide any actionable insights or solutions for investors or readers.

Financial Relevance: Yes
Financial Markets Impacted: Shares of CVS Health Corp.

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article pertains to the financial performance of CVS Health Corp. and its impact on the stock market. There is no mention of an extreme event.

Reported publicly: www.marketwatch.com